Position in GH
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,501
+$2,883 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#528
of 593 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tidemark, LLC holds $110,967 across 11 Diagnostics & Research names. GH ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
325 | $57,144 | |
| 2 | DHR |
Danaher Corp /De/
|
88 | $16,762 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
26 | $13,035 | |
| 4 | GH |
Guardant Health, Inc.
This page
|
50 | $7,501 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
26 | $5,896 | |
| 6 | WAT |
Waters Corp /De/
|
14 | $5,250 | |
| 7 | LH |
Labcorp Holdings Inc.
|
12 | $3,360 | |
| 8 | GRAL |
GRAIL, Inc.
|
12 | $819 |
All Filings in GH
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,501 | 50 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,618 | 50 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,107 | 50 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,124 | 50 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,602 | 50 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,130 | 50 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,527 | 50 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,491 | 65 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $433 | 15 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,249 | 206 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,952 | 294 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||